Eupraxia Pharmaceuticals Inc. (EPRX) stock
EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.15+0.34 (+4.35%)
Close on Nov 13, 2026Market cap $491.40MP/E –Yield –
Eupraxia Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Eupraxia Pharmaceuticals's enterprise value was $336.47M on Nov 11, 2026, against $186.67M a year earlier. Over the last 4 years it ranged from $44.64M to $390.49M, with a median of $103.62M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $336.47M | +43.5% |
| 2025 | Dec 31, 2025 | $234.43M | +256.2% |
| 2024 | Dec 31, 2024 | $65.82M | -7.3% |
| 2023 | Dec 29, 2023 | $71.01M | – |
See a number that looks wrong?